
Castleman's disease is a lymphoproliferative disorder characterized by angiofollicular lymph node hyperplasia. Recently, a new variant of multicentric Castleman's disease has been identified in Japan called TAFRO syndrome. It is characterized by a constellation of symptoms: thrombocytopenia, anasarca, reticulin fibrosis of the bone marrow, renal dysfunction and organomegaly (TAFRO). It is usually associated with polyclonal hyperimmunoglobulinemia. Here, we report the first and unique case of TAFRO syndrome with monoclonal gammapathy.
Male, Fever, Castleman Disease, Syndrome, Middle Aged, Blood Protein Electrophoresis, Monoclonal Gammopathy of Undetermined Significance, Immunoglobulin kappa-Chains, Immunoglobulin G, Splenomegaly, Humans, Lymph Nodes, Rituximab, Immunosuppressive Agents, Hepatomegaly
Male, Fever, Castleman Disease, Syndrome, Middle Aged, Blood Protein Electrophoresis, Monoclonal Gammopathy of Undetermined Significance, Immunoglobulin kappa-Chains, Immunoglobulin G, Splenomegaly, Humans, Lymph Nodes, Rituximab, Immunosuppressive Agents, Hepatomegaly
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
